SCHEMBL6011041

SCHEMBL6011041

Cc1ccc(/C=C/C2CCNCC2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.51
KHK P50053 1/20 0.44
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CYP2D6 P10635 1/20 0.41
TRPM8 Q7Z2W7 1/20 0.40
NFE2L2 Q16236 1/20 0.39
MAPT P10636 1/20 0.38
RELA Q04206 1/20 0.37
CA1 P00915 1/20 0.37
KDM1A O60341 1/20 0.36
NPC1 O15118 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ADRB1 P08588 1/20 0.36
HTR2C P28335 1/20 0.36
FOS P01100 1/20 0.36
JUN P05412 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30683539 1.00 MAOB (0.51) MAOBKHKMEN1KMT2ACYP2D6
Hydrochloric Acid SCHEMBL27035873 0.98 MAOB (0.50) MAOBKHKMEN1KMT2ACYP2D6
Hydrochloric Acid SCHEMBL27134589 0.98 MAOB (0.50) MAOBKHKMEN1KMT2ACYP2D6
SCHEMBL27618022 0.81 KHK (0.39) MAOBKHKMEN1KMT2ACYP2D6
SCHEMBL6011685 0.81 MAOB (0.51) MAOBKHKCYP2D6KDM1AALDH1A1
SCHEMBL27637228 0.81 KHK (0.39) MAOBKHKMEN1KMT2ACYP2D6
SCHEMBL5213208 0.81 MAOB (0.51) MAOBKHKNFE2L2
SCHEMBL10069269 0.81 MAOB (0.51) MAOBKHKMAPTKDM1AALDH1A1
SCHEMBL6011027 0.81 TYR (0.42) MAOBKHKMEN1KMT2ACYP2D6
SCHEMBL20015683 0.81 KDM1A (0.51) MAOBKHKKDM1AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018055096-A1 DISUBTITUTED AZETIDINES, PYRROLIDINES, PIPERIDINES AND AZEPANES AS INHIBITORS OF MONOAMINE OXIDASE B FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES UNIVERSITY OF LJUBLJANA (SI) 2018-03-29 WO disclosed
EP-1785415-B1 PIPERIDINE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF ASTELLAS PHARMA INC (JP) 2012-05-02 EP disclosed
EP-1785415-A1 PIPERIDINE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Astellas Pharma Inc. (JP) 2007-05-16 EP disclosed